Abstract
The recent, fast track advancements in the field of nanotechnology have encouraged the use of nanoparticles as nanomedicine in the biomedical field. Especially, the special class of magnetic materials such as superparamagnetic nanomaterials are highly recommended in cancer theranostics (diagnosis and therapeutics). Mechanistic studies of these superparamagnetic nanomaterials mean the biological processes associated with the nanomaterials coming in contact with the biological environment. The biological environment quickly interacts with the nanomaterials, remodels their structure i.e. formation of protein corona results in changes in their physicochemical properties which is responsible for their biodistribution, biotransformation, potential toxicity and fate. The biodistribution and fate of superparamagnetic nanomaterials determines the effectiveness and safety of the cancer nanomedicine. In order to use the cancer nanomedicine very efficiently it is important to understand the mechanistic studies very well. The chapter involves the understanding of mechanistic studies of superparamagnetic nanomaterials. The main focus is on the biodistribution, biotransformation, toxicity and fate or elimination pathways followed by nanomaterials after their short term and long term exposure. Although, the use of nanomedicine is highly advanced, the mechanistic studies from exposure to long term fate of newly synthesized nanomaterials must be cautiously evaluated prior actual clinical use. Current understanding of the adverse effects and the exact fate of the nanomaterials inside the human body is very inadequate.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Akbarzadeh A, Samiei M, Davaran S (2012) Magnetic nanoparticles: preparation, physical properties, and applications in biomedicine. Nanoscale Res Lett 7(1):144
Almeida JPM, Chen AL, Foster A, Drezek R (2011) In vivo biodistribution of nanoparticles. Nanomedicine 6(5):815–835
Ankamwar B, Lai TC, Huang JH, Liu RS, Hsiao M, Chen CH et al (2010) Biocompatibility of Fe(3)O(4) nanoparticles evaluated by in vitro cytotoxicity assays using normal, glia and breast cancer cells. Nanotechnology 21(7):75102
Anzai Y, Piccoli CW, Outwater EK, Stanford W, Bluemke DA, Nurenberg P et al (2003) Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study. Radiology 228(3):777–788
Arami H, Khandhar A, Liggitt D, Krishnan KM (2015) In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles. Chem Soc Rev 44(23):8576–8607
Baboci L, Capolla S, Di Cintio F, Colombo F, Mauro P, Dal Bo M et al (2020) The dual role of the liver in nanomedicine as an actor in the elimination of nanostructures or a therapeutic target. 2020:4638192
Bancos S, Stevens DL, Tyner KM (2014) Effect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitro. Int J Nanomed 10:183–206
Bohara RA, Thorat ND (2018) Hybrid nanostructures for cancer theranostics. Elsevier
Bourrinet P, Bengele HH, Bonnemain B, Dencausse A, Idee J-M, Jacobs PM et al (2006) Preclinical safety and pharmacokinetic profile of ferumoxtran-10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agent. Invest Radiol 41(3):313–324
Chandra S, Barick K, Bahadur D (2011) Oxide and hybrid nanostructures for therapeutic applications. Adv Drug Deliv Rev 63(14–15):1267–1281
Chen H, Wu X, Duan H, Wang YA, Wang L, Zhang M et al (2009) Biocompatible polysiloxane-containing diblock copolymer PEO-b-PγMPS for coating magnetic nanoparticles. ACS Appl Mater Interfaces 1(10):2134–2140
Chen H, Wang L, Yeh J, Wu X, Cao Z, Wang YA et al (2010) Reducing non-specific binding and uptake of nanoparticles and improving cell targeting with an antifouling PEO-b-PγMPS copolymer coating. Biomaterials 31(20):5397–5407
Cho WS, Cho M, Jeong J, Choi M, Cho HY, Han BS et al (2009) Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. Toxicol Appl Pharmacol 236(1):16–24
Chouly C, Pouli quen D, Lucet I, Jeune JJ, Jallet P (1996) Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution. J Microencapsul 13:245–255
Cole A, David A, Wang J. Galbán CJ, Hill HL, Yang VC (2011) Polyethylene glycol modified, cross-linked starch-coated iron oxide nanoparticles for enhanced magnetic tumor targeting. Biomaterials 32(8):2183–2193
Croissant JG, Fatieiev Y, Khashab NM (2017) Degradability and clearance of silicon, organosilica, silsesquioxane, silica mixed oxide, and mesoporous silica nanoparticles. Adv Mater 29(9):1604634
De Matteis V (2017) Exposure to inorganic nanoparticles: routes of entry, immune response, biodistribution and in vitro/in vivo toxicity evaluation. Toxics 5(4):29
Du B, Yu M, Zheng J (2018) Transport and interactions of nanoparticles in the kidneys. Nat Rev Mater 3(10):358–374
Dulińska-Litewka J, Łazarczyk A, Hałubiec P, Szafrański O, Karnas K, Karewicz A (2019) Superparamagnetic iron oxide nanoparticles—current and prospective medical applications. Materials 12(4):617
Dung NT, Linh NT, Chi DL, Hoa NT, Hung NP, Ha NT et al (2021) Optical properties and stability of small hollow gold nanoparticles. RSC Adv 11(22):13458–13465
Elbialy NS, Aboushoushah SF, Alshammari WW (2019) Long-term biodistribution and toxicity of curcumin capped iron oxide nanoparticles after single-dose administration in mice. Life Sci 230:76–83
Feng Q, Liu Y, Huang J, Chen K, Huang J, Xiao K (2018) Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings. Sci Rep 8(1):2082
Foy SP, Manthe RL, Foy ST, Dimitrijevic S, Krishnamurthy N, Labhasetwar V (2010) Optical imaging and magnetic field targeting of magnetic nanoparticles in tumors. ACS Nano 4(9):5217–5224
Gabbasov R, Cherepanov V, Chuev M, Polikarpov M, Nikitin M, Deyev S et al (2013) Biodegradation of magnetic nanoparticles in mouse liver from combined analysis of Mössbauer and magnetization data. IEEE Trans Magn 49(1):394–397
Gertz F, Azimov R, Khitun A (2012) Biological cell positioning and spatially selective destruction via magnetic nanoparticles. Appl Phys Lett 101(1):013701
Giram PS, Garnaik B (2021) Evaluation of biocompatibility of synthesized low molecular weight PLGA copolymers using zinc L-proline through green route for biomedical application. Polym Adv Technol 32(11):4502–4515
Gupta AK, Gupta M (2005) Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26(18):3995–4021
Jain TK, Reddy MK, Morales MA, Leslie-Pelecky DL, Labhasetwar V (2008) Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats. Mol Pharm 5(2):316–327
Jones SW, Roberts RA, Robbins GR, Perry JL, Kai MP, Chen K et al (2013) Nanoparticle clearance is governed by Th1/Th2 immunity and strain background. J Clin Investig 123(7):3061–3073
Kolosnjaj-Tabi J, Javed Y, Lartigue L, Volatron J, Elgrabli D, Marangon I et al (2015) The one year fate of iron oxide coated gold nanoparticles in mice. ACS Nano 9(8):7925–7939
Kolosnjaj-Tabi J, Lartigue L, Javed Y, Luciani N, Pellegrino T, Wilhelm C et al (2016) Biotransformations of magnetic nanoparticles in the body. Nano Today 11(3):280–284
Larsen EK, Nielsen T, Wittenborn T, Birkedal H, Vorup-Jensen T, Jakobsen MH et al (2009) Size-dependent accumulation of PEGylated silane-coated magnetic iron oxide nanoparticles in murine tumors. ACS Nano 3(7):1947–1951
Lartigue L, Alloyeau D, Kolosnjaj-Tabi J, Javed Y, Guardia P, Riedinger A et al (2013) Biodegradation of iron oxide nanocubes: high-resolution in situ monitoring. ACS Nano 7(5):3939–3952
Levy M, Luciani N, Alloyeau D, Elgrabli D, Deveaux V, Pechoux C et al (2011) Long term in vivo biotransformation of iron oxide nanoparticles. Biomaterials 32(16):3988–3999
Liu Y, Hardie J, Zhang X, Rotello VM (2017) Effects of engineered nanoparticles on the innate immune system. Semin Immunol 34:25–32
Longmire M, Choyke PL, Kobayashi H (2008) Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine (Lond) 3(5):703–717
MacParland SA, Tsoi KM, Ouyang B, Ma XZ, Manuel J, Fawaz A et al (2017) Phenotype determines nanoparticle uptake by human macrophages from liver and blood. 11(3):2428–2443
Mahmoudi M, Laurent S, Shokrgozar MA, Hosseinkhani M (2011) Toxicity evaluations of superparamagnetic iron oxide nanoparticles: cell “vision” versus physicochemical properties of nanoparticles. ACS Nano 5(9):7263–7276
Mao R, Wang J, Pei J, Wu S, Feng J, Lin Y et al (2013) Pharmacokinetics and applications of magnetic nanoparticles. Curr Drug Metab 14(8):872–878
Martinkova P, Brtnicky M, Kynicky J, Pohanka M (2018) Iron oxide nanoparticles: innovative tool in cancer diagnosis and therapy. Adv Healthc Mater 7(5):1700932
Masthoff M, Buchholz R, Beuker A, Wachsmuth L, Kraupner A, Albers Fet al (2019) Introducing specificity to iron oxide nanoparticle imaging by combining (57)Fe-based MRI and mass spectrometry. 19(11):7908–7917
Mejías R, Gutiérrez L, Salas G, Pérez-Yagüe S, Zotes TM, Lázaro FJ et al (2013) Long term biotransformation and toxicity of dimercaptosuccinic acid-coated magnetic nanoparticles support their use in biomedical applications. J Control Release: Off J Control Release Soc 171(2):225–233
Müller K, Skepper JN, Posfai M, Trivedi R, Howarth S, Corot C et al (2007) Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro. Biomaterials 28(9):1629–1642
Papisov M, Bogdanov A Jr, Schaffer B, Nossiff N, Shen T, Weissleder R et al (1993) Colloidal magnetic resonance contrast agents: effect of particle surface on biodistribution. J Magn Magn Mater 122(1–3):383–386
Patil RM (2020) Nanomedicine for early diagnosis of breast cancer. Nanomedicines for breast cancer theranostics. Elsevier, pp 153–173
Patil RM, Shete PB (2019) Biodistribution and cellular interaction of hybrid nanostructures. Hybrid nanostructures for cancer theranostics. Elsevier, pp 63–86
Patil R, Shete P, Thorat N, Otari S, Barick K, Prasad A et al (2014) Non-aqueous to aqueous phase transfer of oleic acid coated iron oxide nanoparticles for hyperthermia application. RSC Adv 4(9):4515–4522
Patil R, Shete P, Patil S, Govindwar S, Pawar S (2015) Superparamagnetic core/shell nanostructures for magnetic isolation and enrichment of DNA. RSC Adv 5(107):88375–88381
Patil RM, Bauer J, Thorat ND (2019) Strengths and limitations of physical stimulus in breast cancer nanomedicine. External field and radiation stimulated breast cancer nanotheranostics, vol 9, pp 1–34
Phadatare MR, Khot V, Salunkhe A, Thorat N, Pawar S (2012) Studies on polyethylene glycol coating on NiFe2O4 nanoparticles for biomedical applications. J Magn Magn Mater 324(5):770–772
Poon W, Zhang Y-N, Ouyang B, Kingston BR, Wu JLY, Wilhelm S et al (2019) Elimination pathways of nanoparticles. ACS Nano 13(5):5785–5798
Rojas JM, Gavilán H, Del Dedo V, Lorente-Sorolla E, Sanz-Ortega L, da Silva GB et al (2017) Time-course assessment of the aggregation and metabolization of magnetic nanoparticles. Acta Biomater 58:181–195
Ruiz A, Gutiérrez L, Cáceres-Vélez PR, Santos D, Chaves SB, Fascineli ML et al (2015) Biotransformation of magnetic nanoparticles as a function of coating in a rat model. Nanoscale 7(39):16321–16329
Salunkhe AB, Khot VM, Ruso JM, Patil S (2016) Water dispersible superparamagnetic cobalt iron oxide nanoparticles for magnetic fluid hyperthermia. J Magn Magn Mater 419:533–542
Schrand A, Johnson J, Dai L, Hussain SM, Schlager J, Zhu L et al (2009) Safety of nanoparticles. From manufacturing to medical applications, nanostructure science and technology, pp 159–187
Schreck R, Albermann K, Baeuerle PA (1992) Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radical Res Commun 17(4):221–237
Semerad J, Pacheco NIN (2020) In vitro study of the toxicity mechanisms of nanoscale zero-valent iron (nZVI) and released iron ions using earthworm cells. 10(11)
Senthilkumar N, Sharma PK, Sood N, Bhalla N (2021) Designing magnetic nanoparticles for in vivo applications and understanding their fate inside human body. Coord Chem Rev 445:214082
Seo DY, Jin M, Ryu J-C, Kim Y-J (2017) Investigation of the genetic toxicity by dextran-coated superparamagnetic iron oxide nanoparticles (SPION) in HepG2 cells using the comet assay and cytokinesis-block micronucleus assay. Toxicol Environ Heal Sci 9(1):23–29
Shete P, Patil R, Ningthoujam R, Ghosh S, Pawar S (2013) Magnetic core–shell structures for magnetic fluid hyperthermia therapy application. New J Chem 37(11):3784–3792
Soares GA, Faria JVC, Pinto LA, Prospero AG, Pereira GM, Stoppa EG (2022) Long-term clearance and biodistribution of magnetic nanoparticles assessed by AC biosusceptometry. 15(6)
Soenen SJ, De Cuyper M (2010) Assessing iron oxide nanoparticle toxicity in vitro: current status and future prospects. Nanomedicine 5(8):1261–1275
Stepien G, Moros M, Pérez-Hernández M, Monge M, Gutiérrez L, Fratila RM et al (2018) Effect of surface chemistry and associated protein corona on the long-term biodegradation of iron oxide nanoparticles in vivo. ACS Appl Mater Interfaces 10(5):4548–4560
Stern ST, Adiseshaiah PP, Crist RM (2012) Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity. Part Fibre Toxicol 9(1):1–17
Stoddart MJ (2011) Cell viability assays: introduction. Methods Mol Biol (clifton, NJ) 740:1–6
Thorat N, Otari S, Patil R, Bohara R, Yadav H, Koli V et al (2014) Synthesis, characterization and biocompatibility of chitosan functionalized superparamagnetic nanoparticles for heat activated curing of cancer cells. Dalton Trans 43(46):17343–17351
Tomasovicova N, Khmara I, Koneracka M, Zavisova V, Kubovcikova M, Antal I et al (2017) Elimination of magnetic nanoparticles with various surface modifications from the bloodstream in vivo. Acta Phys Pol A 131(4):1159–1161
Tseng W-K, Chieh J-J, Yang Y-F, Chiang C-K, Chen Y-L, Yang SY et al (2012) A noninvasive method to determine the fate of Fe3O4 Nanoparticles following intravenous injection using scanning SQUID biosusceptometry. PLoS ONE 7(11):e48510
Van de Walle A, Kolosnjaj-Tabi J, Lalatonne Y, Wilhelm C (2020) Ever-evolving identity of magnetic nanoparticles within human cells: the interplay of endosomal confinement, degradation, storage, and neocrystallization. Acc Chem Res 53(10):2212–2224
Veranth JM, Kaser EG, Veranth MM, Koch M, Yost GS (2007) Cytokine responses of human lung cells (BEAS-2B) treated with micron-sized and nanoparticles of metal oxides compared to soil dusts. Part Fibre Toxicol 4:2
Wang H, Joseph JA (1999) Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radical Biol Med 27(5–6):612–616
Wang J, Chen Y, Chen B, Ding J, Xia G, Gao C et al (2010) Pharmacokinetic parameters and tissue distribution of magnetic Fe3O4 nanoparticles in mice. Int J Nanomed 5:861
Weissleder R, Stark DD, Engelstad BL, Bacon BR, Compton CC, White DL et al (1989) Superparamagnetic iron oxide: pharmacokinetics and toxicity. Am J Roentgenol 152(1):167–173
Weissleder R, Cheng HC, Bogdanova A, Bogdanov A Jr (1997) Magnetically labeled cells can be detected by MR imaging. J Magn Resonance Imaging: JMRI 7(1):258–263
Wu W, Wu Z, Yu T, Jiang C, Kim W-S (2015) Recent progress on magnetic iron oxide nanoparticles: synthesis, surface functional strategies and biomedical applications. Sci Technol Adv Mater 16(2):023501
Yoo J-W, Chambers E, Mitragotri S (2010) Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects. Curr Pharm Des 16(21):2298–2307
Yu Q, Xiong XQ, Zhao L, Xu TT, Bi H, Fu R et al (2018) Biodistribution and toxicity assessment of superparamagnetic iron oxide nanoparticles in vitro and in vivo. Curr Med Sci 38(6):1096–1102
Zelepukin IV, Yaremenko AV, Ivanov IN, Yuryev MV, Cherkasov VR, Deyev SM et al (2021) Long-term fate of magnetic particles in mice: a comprehensive study. ACS Nano 15(7):11341–11357
Zhao W, Liu Q, Zhang X, Su B, Zhao C (2018) Rationally designed magnetic nanoparticles as anticoagulants for blood purification. Colloids Surf B 164:316–323
Acknowledgements
The author is thankful to Director, Directorate of Forensic Science Laboratories, Kalina, Mumbai and Deputy Director, Regional Forensic Science Laboratory, Nashik, Home Department, M.S. for their constant encouragement, motivation, valuable and kind support. N.D.T. acknowledges funding under the Science Foundation Ireland and Irish Research Council (SFI-IRC) pathway program (21/PATH-S/9634).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Patil, R.M., Shete, P.B., Giram, P.S., Somvanshi, S.B., Thorat, N.D. (2023). In Vivo Mechanistic Study of Superparamagnetic Materials. In: Thorat, N., Sahu, N.K. (eds) Superparamagnetic Materials for Cancer Medicine. Nanomedicine and Nanotoxicology. Springer, Cham. https://doi.org/10.1007/978-3-031-37287-2_11
Download citation
DOI: https://doi.org/10.1007/978-3-031-37287-2_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-37286-5
Online ISBN: 978-3-031-37287-2
eBook Packages: MedicineMedicine (R0)